Global and china catheter market

Global And China Catheter Market, By Product Type (Cardiovascular Catheter, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, Specialty Catheters), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Request Free Sample

Jul 2023
CMI4010
180 Pages
Excel & Pdf
Medical Devices

Summary

The global and china catheter market is estimated to be valued at US$ 46.8 Billion in 2023 and is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).

Analysts’ Views on Global And China Catheter Market:

The growing demand for minimally invasive procedures can also be attributed to recent technological innovations, the use of antimicrobial coating and miniaturized catheters to prevent the risk of restenosis. These procedures have higher adoption rates and are becoming standard techniques in general surgery due to the use of advanced technologies and innovative coated catheters available in the market. Thus, the growing preference for minimally invasive surgeries is expected to drive the growth of the global and china catheter market during the forecast period.

Figure 1. Global And China Catheter Market Share (%), By Product Type, 2023

Global And China Catheter Market– Driver

Increasing prevalence of chronic disorders

Increasing prevalence of chronic disorders is expected to propel growth of the global and China catheters market over the forecast period. For instance, according to the American Heart Association's Heart and Stroke Statistics 2022 update, National prevalence of any chronic diseases was 81.1% (95% Cardiac index 80.9-81.2), representing 179.9 billion Chinese older adults. The prevalence increased with aging and peaked at 80 to 84 years old (87.2, 95% CI 86.7-87.7), this is consistent with studies in China.

Growing geriatric population

Growing geriatric population can also drive the global and china catheter market growth. For instance, according to an article published in World Health Orgnisation in November 2022, reported 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). Non- cystic fibrosis bronchiectasis is the most common in elderly and frailer patients with estimated cases of 50% in patients over 65 years of age and 19.1% in patients over 75 years old.

Figure 2. Global And China Catheter Market Share (%), By Region, 2023

Global And China Catheter Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global and china catheter market over the forecast period. North America is estimated to hold 36.3% of the market share North America holds a significant market share in the catheter market worldwide, mainly due to the key market players are focusing on research and developemnet of catheters. For instance, in November 2021, Aytu BioPharma, a U.S.-based pharmaceutical business, reported that the U.S. Patent and Trademark Office had granted it a U.S. patent for the Healight ultraviolet-A light-based pulmonary catheter.

Global And China Catheter Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global and china catheter market. Product launches amid the pandemic were also anticipated to have a positive impact on the market’s growth. For instance, in April 2020, Bactiguard is a medtech company, introduced a new urinary catheter, the BIP Foley TempSensor, for continuous temperature monitoring in patients. Such factors collectively bolstered the market's growth over the pandemic phase.

Global and China Catheter Market Report Coverage

Report Coverage	Details
Base Year:	2022	Market Size in 2023:	US$ 46.8 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 to 2030
Forecast Period 2023 to 2030 CAGR:	5.1%	2030 Value Projection:	US$ 66.5 Bn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Cardiovascular catheter, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, Specialty Catheters By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Companies covered:	Cordis (Cardinal Health), Abbott Laboratories, B. BRAUN, Medtronic plc, Terumo, Teleflex Corporation, C. R. Bard, Inc., RIST Neurovascular, Inc., Edwards Lifesciences, Cook Medical Incorporated, Merit Medical, Biotronik, BALT, Osypka AG, Japan Lifeline, ACT, Lepu, Microport, SCW Medicath, Boston Scientific Corporation, Coloplast A/S, Convatec Group PLC, Dentsply, Bactiguard, Hollister Incorporated, Pacific Hospital Supply Co. Ltd., Rochester Medical Corporation, Fuqing Medical, Medsuyun, Songhang, Sanli, Chensheng Medical, Haiou Medical, CATHETRIX, and World Medical.
Growth Drivers:	Increasing prevalence of chronic disorders Growing geriatric population
Restraints & Challenges:	High cost of the cardiac catheterization procedure

Global And China Catheter Market Segmentation:

The global and china catheter market report is segmented into By Product Type, By End User, and By Region.

By Product Type, the global and china catheter market is segmented into cardiovascular catheter, urology catheters, intravenous catheters, neurovascular catheters, and specialty catheters. Out of which, the cardiovascular catheter is expected to dominate the global and china catheter market during the forecast period and this is atributed to high prevelance of cardiac disease.

By End User, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. Out of which, the hospitals segment is expected to dominate the market over the forecast period and this is attributed increasing use of catheter in the surgeris.

Among all the segmentations, the end user has the potential due to the rising chronic disorders have become the most dominant cause of mortality and morbidity globally this is expected to drive the growth of the segment over the forecast period. According to the Brain Aneurysm Foundation, in March 2021, globally, approximately 500,000 deaths are caused by brain aneurysms every year, and half of such individuals are aged 50 or below. The annual rate of rupture is around 8-10 people per 100,000 or about 30,000 people in the U.S.

Global And China Catheter Market Cross Sectional Analysis:

North America is expected to dominate the global and china catheter market over the forecast period, owing to exapand the distributuion in other contries is boosting the market in the region. For instance, In November 2021, The Flume Catheter Company Ltd., is a medical device company, founded in the UK , announced that the U.S. Food and Drug Administration (FDA) has granted it permission to market the FLUME catheter in the U.S.

Global And China Catheter Market: Key Developments

On May 19, 2023 Abbott Laboratories, announced that the U.S. Food and Drug Administration (FDA) has approved the company's TactiFlex Ablation Catheter, Sensor Enabled, the world's first ablation catheter with a flexible tip and contact force technology. it is used to perform an ablation procedure to treat atrial fibrillation (AFib), the most common abnormal heart rhythm.

In February 2022, Medtronic plc, is a healthcare technology company, announced that the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters are the first and only ablation catheters approved by the U.S. Food and Drug Administration (FDA) to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

In October 2020, Cardinal Health, a cardiovascular and endovascular solutions company, announced several strategic distribution agreements that will enable Cordis, a Cardinal Health’s interventional vascular business, to rapidly expand its product portfolio in select countries globally. These distribution agreements, which add coronary stents and percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, expand Cordis’ portfolio of innovative products that support the treatment of patients undergoing percutaneous coronary intervention (PCI) from access to intervention and closure.

In December 2022, Medtronic plc, a medical technology company, announced the completion of enrollment and final treatment in the SPHERE Per-AF Trial, a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal trial designed to evaluate the safety and effectiveness of the first-of-its kind Sphere-9 pulsed field (PF) and radiofrequency (RF) ablation, and high density (HD) mapping catheter with the Affera cardiac mapping and navigation platform for the treatment of persistent atrial fibrillation (AF).

Global And China Catheter Market: Key Trends

Increasing prevalence of urinary incontinence

Increasing prevalence of urinary incontinence is demand for Foley catheters is expected to offer lucrative growth opportunities for players in the global and china catheter market. For instance, according to the paper, “The prevalence of urinary incontinence,” published in the Journal Climacteric, in June 2021, the prevalence of Urinary incontinence (UI) ranged from approximately 50% to 70%, with most studies reporting a prevalence of any urinary incontinence in the range of 25-45%. Severe incontinence has a low prevalence in young women, but rapidly increases at ages 70 through 80. In men, the prevalence of incontinence is much lower than in women, about 3% to 11% overall, with urge incontinence accounting for 40% to 80% of all male patients. Stress incontinence accounts for less than 10% of cases and is attributable to prostate surgery, trauma, or neurological injury.

Global And China Catheter Market: Restraint

High cost of the cardiac catheterization procedure

High cost of the cardiac catheterization procedure is expected to hinder growth of the market. For instance, Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world, and Medtronic is a leader in medical technology, services, and solutions whose products are used in a broad range of interventional medical specialties, announced Coronary stents, priced at about 13,000 yuan (US$1,961) each, are expected to become available in Chinese hospitals for the treatment of coronary heart disease. The cost of cardiac catheterization with & without coronary angiogram ranges from US$ 3,000 to US$ 5,000.

Key Market Players are focusing on manufacturing of cost effective product.

Global And China Catheter Market- Key Players

Major players operating in the global and China catheter market include Cordis (Cardinal Health), Abbott Laboratories, B. BRAUN, Medtronic plc, Terumo, Teleflex Corporation, C. R. Bard, Inc., RIST Neurovascular, Inc., Edwards Lifesciences, Cook Medical Incorporated, Merit Medical, Biotronik, BALT, Osypka AG, Japan Lifeline, ACT, Lepu, Microport, SCW Medicath, Boston Scientific Corporation, Coloplast A/S, Convatec Group PLC, Dentsply, Bactiguard, Hollister Incorporated, Pacific Hospital Supply Co. Ltd., Rochester Medical Corporation, Fuqing Medical, Medsuyun, Songhang, Sanli, Chensheng Medical, Haiou Medical, CATHETRIX, and World Medical.

*Defination: A catheter is a small, flexible tube used to treat many medical diseases, including those related to the heart, urology, gastrointestinal tract, and nervous system, among others. Hollow, pliable tubes called urinary catheters are placed into the bladder to drain urine. People who are unable to empty their bladders owing to medical issues spontaneously use catheters. Catheters can remain in place for weeks and come in a variety of materials. Additionally, catheters may be implanted temporarily or permanently into the brain, skin, and ducts.

Table of Content

Table of Contents

*Browse 36 market data tables and 33 figures on “Global And China Catheter Market ” - Global And China Forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global and china catheter market during the forecast period (2023-2030)?

The global and China catheter market is estimated to be valued at US$ 46.8 Billion in 2023 and is expected to exhibit a CAGR of 5.1% between 2023 and 2030.

What are the major factors driving the market growth?

Increasing prevalence of chronic disorders and Growing geriatric population are expected to propel growth to expand the product portfolio is expected to drive the market growth.

Which is the leading Product type segment in the market?

Cardiovascular catheter is the leading segment in the market.

What are the key factors hampering the growth of the market?

High cost of the cardiac catheterization procedure are expected to hinder the market over the forecast period.

Which are the major players operating in the market?

Major players operating in the market include Cordis (Cardinal Health), Abbott Laboratories, B. BRAUN, Medtronic plc, Terumo, Teleflex Corporation, C. R. Bard, Inc., RIST Neurovascular, Inc., Edwards Lifesciences, Cook Medical Incorporated, Merit Medical, Biotronik, BALT, Osypka AG, Japan Lifeline, ACT, Lepu, Microport, SCW Medicath, Boston Scientific Corporation, Coloplast A/S, Convatec Group PLC, Dentsply, Bactiguard, Hollister Incorporated, Pacific Hospital Supply Co. Ltd., Rochester Medical Corporation, Fuqing Medical, Medsuyun, Songhang, Sanli, Chensheng Medical, Haiou Medical, CATHETRIX, and World Medical.